Paper Alert: Intranasal Insulin Data Fuels Push for Phase 2B Trial
cognitive and functional tests, as well as CSF biomarker and imaging endpoints, she told ARF.—Esther
378 RESULTS
You searched Esther
Sort By:
cognitive and functional tests, as well as CSF biomarker and imaging endpoints, she told ARF.—Esther
story).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3172 Parkinson's Disease Proteostasis
said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3286 Parkinson's Disease LRRK2
and probably a lot safer,” she told ARF.—Esther Landhuis. This is Part 2 of a two-part series. See also Part 1.
story; Gandy et al., 2010).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2439
white matter change through a CAA route.—Esther Landhuis None
event that, if sustained, seems to add to the AD risk conferred by the ApoE4 gene.—Esther Landhuis. None
to be lipidated to achieve that remains unclear.—Esther Landhuis None
conference story).—Esther Landhuis. Reference: Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M,
fit into the pathogenic process (Jack et al., 2010 and ARF Live Discussion).—Esther Landhuis None
or a combined increase in Aβ production with impaired efflux from parenchyma to CSF,” they noted.—Esther
a drug…that’s a drop in the bucket.”—Esther Landhuis Esther Landhuis is a science journalist in Dublin,
compounds, showed they were having a silent heart attack.—Esther Landhuis None
the mechanisms involved.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2292 Alzheimer's
of other AD drug candidates, Lipton said.—Esther Landhuis None